210 related articles for article (PubMed ID: 34853944)
1. The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy.
Gangi A; Shah R
Ann Surg Oncol; 2022 Mar; 29(3):2056-2068. PubMed ID: 34853944
[TBL] [Abstract][Full Text] [Related]
2. Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasms.
Narasimhan V; Pham T; Warrier S; Craig Lynch A; Michael M; Tie J; Ramsay R; Heriot A
ANZ J Surg; 2019 Sep; 89(9):1035-1040. PubMed ID: 30685879
[TBL] [Abstract][Full Text] [Related]
3. Patients undergoing cytoreductive surgery for peritoneal malignancy of appendiceal origin should be consented for umbilical excision as 30% have umbilical infiltration.
Sakata S; Tan TG; Kostadinov D; Ahmadi N; Dayal SP; Tzivanakis A; Mohamed F; Carr NJ; Cecil TD; Moran BJ
Colorectal Dis; 2021 May; 23(5):1153-1157. PubMed ID: 33544973
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis.
Pallas N; Karamveri C; Kyziridis D; Hristakis C; Kyriakopoulos V; Kalakonas A; Vaikos D; Tentes AK
J BUON; 2017; 22(6):1547-1553. PubMed ID: 29332351
[TBL] [Abstract][Full Text] [Related]
5. Patient Selection for Cytoreductive Surgery.
Grotz TE; Fournier KF; Mansfield PF
Surg Oncol Clin N Am; 2018 Jul; 27(3):443-462. PubMed ID: 29935682
[TBL] [Abstract][Full Text] [Related]
6. ASO Author Reflections: Time to Change: Redefining "Complete Cytoreduction" in Appendiceal Carcinomatosis.
Munoz-Zuluaga C; King MC; Gushchin V; Sardi A
Ann Surg Oncol; 2020 Dec; 27(13):5037-5038. PubMed ID: 32935268
[No Abstract] [Full Text] [Related]
7. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ
Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
[TBL] [Abstract][Full Text] [Related]
8. Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series.
Guaglio M; Sinukumar S; Kusamura S; Milione M; Pietrantonio F; Battaglia L; Guadagni S; Baratti D; Deraco M
Ann Surg Oncol; 2018 Apr; 25(4):878-884. PubMed ID: 29270877
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.
Chow FC; Yip J; Foo DC; Wei R; Choi HK; Ng KK; Lo OS
Asian J Surg; 2021 Jan; 44(1):221-228. PubMed ID: 32605790
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and prognostic factors of cytoreductive surgery and perioperative intraperitoneal chemotherapy in high-volume peritoneal carcinomatosis.
Kyang LS; Dewhurst SL; See VA; Alzahrani NA; Morris DL
Int J Hyperthermia; 2022; 39(1):1106-1114. PubMed ID: 35993246
[TBL] [Abstract][Full Text] [Related]
11. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.
Sugarbaker PH; Chang D
Ann Surg Oncol; 1999 Dec; 6(8):727-31. PubMed ID: 10622499
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases.
Votanopoulos KI; Russell G; Randle RW; Shen P; Stewart JH; Levine EA
Ann Surg Oncol; 2015 Apr; 22(4):1274-9. PubMed ID: 25319583
[TBL] [Abstract][Full Text] [Related]
13. Incomplete cytoreduction with peritoneal metastases from appendiceal mucinous neoplasms.
Sugarbaker PH; Chang D
J Surg Oncol; 2022 Dec; 126(8):1462-1470. PubMed ID: 36102369
[TBL] [Abstract][Full Text] [Related]
14. Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin.
Milovanov V; Sardi A; Aydin N; Nieroda C; Sittig M; Nunez M; Gushchin V
Eur J Surg Oncol; 2015 Jul; 41(7):881-5. PubMed ID: 25899982
[TBL] [Abstract][Full Text] [Related]
15. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A
Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
[TBL] [Abstract][Full Text] [Related]
16. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
Ihemelandu C; Mavros MN; Sugarbaker P
Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
[TBL] [Abstract][Full Text] [Related]
17. Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination.
Huang Y; Alzahrani NA; Chua TC; Morris DL
Dis Colon Rectum; 2017 Apr; 60(4):360-367. PubMed ID: 28267002
[TBL] [Abstract][Full Text] [Related]
18. The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy.
Moran B; Cecil T; Chandrakumaran K; Arnold S; Mohamed F; Venkatasubramaniam A
Colorectal Dis; 2015 Sep; 17(9):772-8. PubMed ID: 25880479
[TBL] [Abstract][Full Text] [Related]
19. Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy.
Sutton PA; O'Dwyer ST; Barriuso J; Aziz O; Selvasekar CR; Renehan AG; Wilson MS
Surg Oncol; 2021 Sep; 38():101572. PubMed ID: 33915487
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of neoadjuvant chemotherapy before CRS-HIPEC for patients with appendiceal cancer.
Chen JC; Beal EW; Hays J; Pawlik TM; Abdel-Misih S; Cloyd JM
J Surg Oncol; 2020 Sep; 122(3):388-398. PubMed ID: 32383206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]